NCT00047047View on ClinicalTrials.gov

Tanespimycin, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

August 31, 2002

Primary Completion Date

September 30, 2007

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

gemcitabine hydrochloride

Given IV

DRUG

tanespimycin

Given IV

DRUG

cisplatin

Given IV

OTHER

laboratory biomarker analysis

Correlative studies

Trial Locations (1)

55905

Mayo Clinic, Rochester

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00047047 - Tanespimycin, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Advanced Solid Tumors | Biotech Hunter | Biotech Hunter